restructuring

Qiagen reported after the close of the market Monday that it will cut between 8 percent and 10 percent of its global workforce in a reorganization intended to improve efficiency and resource allocation.

Thermo Fisher Scientific has reduced its headcount by about 890 through the first nine months of the year, including 450 during the third quarter, it disclosed in it quarterly earnings document filed today with the US Securities and Exchange Commission.

NEW YORK (GenomeWeb News) – Affymetrix reported after the close of the market Wednesday that its third-quarter revenues dropped around 14 percent year over year on lower product sales.

Illumina filed a document with the US Securities and Exchange Commission disclosing that it will cut 200 jobs from its global workforce.

This article has been updated to include additional information from Illumina's conference call.

NEW YORK (GenomeWeb News) – Abbott today announced that it will split into two separate, publicly-traded companies — one focused on diversified medical products and the other on research-based pharmaceuticals.